We provide personalized drug sensitivity screening services for cancer patients and can screen tumor cells from patients' blood samples to provide personalized drug recommendations to help doctors and patients formulate the best treatment strategy for early intervention and effective treatment and reduce the chance of ineffective drug use.
E.V.A. Select can replace traditional in-vitro drug testing by simply drawing 20 c.c. of blood, solving the problem of traditional in vitro drug tests. With this technology, we can then help the patients discover personalized treatment strategies even when standard treatments have failed.